Kim, Raymond
for the Hereditary Breast Cancer Clinical Study Group
6 papers on CoChatORCID 0000-0002-2147-8674
Most cited papers
- Verified
Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study
Villani, A., Shore, A., Wasserman, J. D., Stephens, D., Kim, R. H., Druker, H., Gallinger, B., Naumer, A., Kohlmann, W., Novokmet, A., et al. (2016) · The Lancet Oncology
BRCA gene mutations in cancerCancer-related Molecular Pathways
Cited by 546
- Verified
Haploinsufficiency of vascular endothelial growth factor related signaling genes is associated with tetralogy of Fallot
Reuter, M. S., Jobling, R., Chaturvedi, R. R., Manshaei, R., Costain, G., Heung, T., Curtis, M., Hosseini, S. M., Liston, E., Lowther, C., et al. (2019) · Genetics in Medicine
Congenital Heart Disease StudiesCongenital heart defects research
Cited by 85
- Verified
Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations
Kotsopoulos, J., Gronwald, J., Huzarski, T., Møller, P., Pal, T., McCuaig, J. M., Singer, C. F., Karlan, B. Y., Aeilts, A., Eng, C., et al. (2024) · JAMA Oncology
BRCA gene mutations in cancerMultiple and Secondary Primary Cancers
Cited by 56
- Verified
Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis
Metcalfe, K., Huzarski, T., Gronwald, J., Kotsopoulos, J., Kim, R., Moller, P., Pal, T., Aeilts, A., Eisen, A., Karlan, B., et al. (2024) · British Journal of Cancer
BRCA gene mutations in cancerGlobal Cancer Incidence and Screening
Cited by 46
- Verified
Genes and pathways implicated in tetralogy of Fallot revealed by ultra-rare variant burden analysis in 231 genome sequences
Manshaei, R., Merico, D., Reuter, M. S., Engchuan, W., Mojarad, B. A., Chaturvedi, R., Heung, T., Pellecchia, G., Zarrei, M., Nalpathamkalam, T., et al. (2020) · Frontiers in Genetics
Genomics and Rare DiseasesCongenital heart defects research
Cited by 36
- Verified
Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation
Kotsopoulos, J., Gronwald, J., Huzarski, T., Aeilts, A., Randall Armel, S., Karlan, B., Singer, C. F., Eisen, A., Tung, N., Olopade, O., et al. (2023) · Breast Cancer Research and Treatment
BRCA gene mutations in cancerCancer Risks and Factors
Cited by 26
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free